Kimberly Gentile, Senior Vice President of Clinical Operations at Biohaven Pharmaceuticals, explores the importance of newer patient-centric clinical trial strategies that can help enable better outcomes. Drug development is my passion. My 30-year career in the pharmaceutical industry has been spent on the frontline of clinical research. I love what I do. I feel connected […]
To read this content in full, you need to login.
Not yet a DDW member? Join now for FREE – it takes less than 2 minutes!